Inventor · disambiguated record
Frank Guerino
Also filed as: GUERINO FRANK
4 granted patents·8 pending applications·10 citations·filing 2004–2023
71Inventor score
Top patents by PatentIndex Score
12 records- 0186US2023320981A1Solid oral pharmaceutical compositions for isoxazoline compoundsINTERVET INC·Filed 2023·Application pending·0 cites
- 0284US9770440B2Solid oral pharmaceutical compositions for isoxazoline compoundsINTERVET INC·Filed 2013·Granted Sep 26, 2017·5 cites·18 claims
- 0376US11712416B2Solid oral pharmaceutical compositions for isoxazoline compoundsINTERVET INC·Filed 2021·Granted Aug 1, 2023·0 cites·14 claims
- 0474US8475818B2Local topical administration formulations containing indoxacarbGUERINO FRANK·Filed 2007·Granted Jul 2, 2013·5 cites·10 claims
- 0570US2020000718A1Solid Oral Pharmaceutical Compositions for Isoxazoline CompoundsINTERVET INC·Filed 2019·Application pending·0 cites
- 0663US2017100377A1Solid Oral Pharmaceutical Compositions for Isoxazoline CompoundsINTERVET INC·Filed 2016·Application pending·0 cites
- 0750US2013345210A1Local topical administration formulations containing indoxacarbDU PONT·Filed 2013·Application pending·0 cites
- 0849US9968617B2Local topical administration formulations containing indoxacarbDU PONT·Filed 2015·Granted May 15, 2018·0 cites·19 claims
- 0948US2023310386A1Injectable pharmaceutical compositions and uses thereofINTERVET INC·Filed 2021·Application pending·0 cites
- 1046US2004247568A1Method for formulation of microbial feed additives with feedFiled 2004·Application pending·0 cites
- 1145US2022296564A1Injectable pharmaceutical compositions and uses thereofINTERVET INC·Filed 2020·Application pending·0 cites
- 1242US2014170199A1Parasiticidal combination comprising indoxacarb and deltamethrinDU PONT·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Frank Guerino files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →